Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scot Garg

Showing results (281-290 of 288) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 288 results.
European Heart Journal|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
American Heart Journal|January 6, 2022
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial designHironori Hara, Patrick W Serruys, Neil O'Leary, et al.
European Heart Journal|March 17, 2026
Angiography-derived fractional flow reserve- vs usual care-guided percutaneous coronary intervention: interim analysis of the PIONEER IV trialPatrick W Serruys, Tsung-Ying Tsai, Joanna J Wykrzykowska, et al.
Lancet (London, England)|May 25, 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialAndreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, et al.
Journal of the American College of Cardiology|December 12, 2025
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK TrialPatrick W Serruys, Akihiro Tobe, Niels van Royen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2024
Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosisNiels van Royen, Ignacio J Amat-Santos, Martin Hudec, et al.
International Journal of Cardiology|April 27, 2026
Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trialAkihiro Tobe, Pieter C Smits, Niels van Royen, et al.
Frontiers in Cardiovascular Medicine|August 2, 2023
Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacementMahmoud Abdelshafy, Patrick W Serruys, Tsung-Ying Tsai, et al.
Pageof 29

Showing results (281-290 of 288) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 288 results.
European Heart Journal|April 24, 2025
Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research ConsortiumSimone Fezzi, Bruno Scheller, Bernardo Cortese, et al.
American Heart Journal|January 6, 2022
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial designHironori Hara, Patrick W Serruys, Neil O'Leary, et al.
European Heart Journal|March 17, 2026
Angiography-derived fractional flow reserve- vs usual care-guided percutaneous coronary intervention: interim analysis of the PIONEER IV trialPatrick W Serruys, Tsung-Ying Tsai, Joanna J Wykrzykowska, et al.
Lancet (London, England)|May 25, 2024
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trialAndreas Baumbach, Niels van Royen, Ignacio J Amat-Santos, et al.
Journal of the American College of Cardiology|December 12, 2025
1-Year Outcomes of Novel Balloon-Expandable vs Contemporary Transcatheter Heart Valves in Severe Aortic Stenosis: The LANDMARK TrialPatrick W Serruys, Akihiro Tobe, Niels van Royen, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 26, 2024
Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosisNiels van Royen, Ignacio J Amat-Santos, Martin Hudec, et al.
International Journal of Cardiology|April 27, 2026
Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trialAkihiro Tobe, Pieter C Smits, Niels van Royen, et al.
Frontiers in Cardiovascular Medicine|August 2, 2023
Quantitative aortography for assessment of aortic regurgitation in the era of percutaneous aortic valve replacementMahmoud Abdelshafy, Patrick W Serruys, Tsung-Ying Tsai, et al.
Pageof 29